臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions
臨床狀態：Active ( AllergyIntoleranceClinicalStatusCodes#active)
驗證狀態：Confirmed ( AllergyIntoleranceVerificationStatusCodes#confirmed)
根本原因或運作機制：Allergy ( AllergyIntoleranceType#allergy)
確定的物質的類別：Food ( AllergyIntoleranceCategory#food)
嚴重程度：High Risk ( AllergyIntoleranceCriticality#high)
過敏或不耐症的識別：堅果過敏(Nut allergy) ( SNOMED CT#91934008)
過敏或不耐症被識別的時間：2023-09-03T10:15:00
病人：Patient/pat-example "陳加玲"
紀錄者：Practitioner/pra-dr-example "王依昇"
被記錄的日期：2023-09-03T14:30:00
關於過敏的資訊來源：Practitioner/pra-nurse-example "陳莉"
最後一次已知反應發生的日期與時間：2023-09-03T14:30:00
暴露於此過敏或不耐症物質的不良反應：
過敏產生的特定物質或醫藥產品：alpha-1,4-Glucan-protein synthase (uridine diphosphate-forming)(Medicinal product containing penicillin and acting as antibacterial agent (product)) ( SNOMED CT#3193000)
與此事件相關的臨床症狀/體徵：Anaphylaxis (disorder)) ( SNOMED CT#39579001)
對整個過敏事件的描述：皮膚發癢、紅腫
嚴重程度：Severe ( AllergyIntoleranceSeverity#severe)
如何接觸到該物質：口服(Oral use) ( SNOMED CT#26643006)
備註：患者在食用堅果後出現皮膚發癢和紅腫，症狀於2023年9月3日下午2:30發作